ECSP961660A - COMBINED THERAPY FOR HIV INFECTION - Google Patents

COMBINED THERAPY FOR HIV INFECTION

Info

Publication number
ECSP961660A
ECSP961660A ECSP961660A ECSP961660A EC SP961660 A ECSP961660 A EC SP961660A EC SP961660 A ECSP961660 A EC SP961660A EC SP961660 A ECSP961660 A EC SP961660A
Authority
EC
Ecuador
Prior art keywords
hiv infection
hiv
combined therapy
inhibition
compound
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Jeffrey A Chodakewitz
Emilio A Emini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961660 priority Critical patent/ECSP961660A/en
Publication of ECSP961660A publication Critical patent/ECSP961660A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El invento se refiere a la combinación de un inhibidor de la proteasa de VIH, compuesto J, 3TC y; opcionalmente, AZT, ddC es útil en la inhibición de la proteasa de VIH, la inhibición de transcriptasa reversa de VIH, la prevención o tratamiento de la infección por VIH y el tratamiento del SIDA, ya sea como compiuetso, sales farmacéuticamente aceptables, ingredientes de la composición farmacéutica aceptables, o en combinación o no con otros antivirales, inmuno modulares, antibióticos o vacunas. También se describe los métodos para tratar el sida y los métodos para la prevención o tratamiento de la infección por VIH.The invention relates to the combination of an HIV protease inhibitor, compound J, 3TC and; optionally AZT, ddC is useful in the inhibition of HIV protease, the inhibition of HIV reverse transcriptase, the prevention or treatment of HIV infection, and the treatment of AIDS, either as a compound, pharmaceutically acceptable salts, ingredients of the acceptable pharmaceutical composition, or in combination or not with other antivirals, immunomodular, antibiotics or vaccines. Also described are methods of treating AIDS and methods for preventing or treating HIV infection.

ECSP961660 1996-01-31 1996-01-31 COMBINED THERAPY FOR HIV INFECTION ECSP961660A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961660 ECSP961660A (en) 1996-01-31 1996-01-31 COMBINED THERAPY FOR HIV INFECTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961660 ECSP961660A (en) 1996-01-31 1996-01-31 COMBINED THERAPY FOR HIV INFECTION

Publications (1)

Publication Number Publication Date
ECSP961660A true ECSP961660A (en) 1997-07-28

Family

ID=42042394

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961660 ECSP961660A (en) 1996-01-31 1996-01-31 COMBINED THERAPY FOR HIV INFECTION

Country Status (1)

Country Link
EC (1) ECSP961660A (en)

Similar Documents

Publication Publication Date Title
MX9204720A (en) QUINAZOLINE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS.
DE60036961D1 (en) GAMMA-HYDROXY-2- (FLUORALKYLAMINOCARBONYL) -1-PIPERAZINE PENTANAMIDE AS AN HIV PROTEASE INHIBITOR
RS50091B (en) Use of retigabine for the treatment of neuropathic pain
ATE175412T1 (en) HIV PROTEASE INHIBITORS
MY109834A (en) Benzoxazinones as inhibitors of hiv reverse transcriptase
ES2186787T3 (en) USE OF RITONAVIR (ABT-538) TO IMPROVE THE PHARMACOCINETICS OF MEDICINES METABOLIZED BY THE CYCROCHROME P450 IN A METHOD OF TREATMENT OF AIDS.
MX9403380A (en) HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS.
ES2178037T3 (en) CYCLOSPORINE DERIVATIVES, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ATE252081T1 (en) NEW HIV PROTEASE INHIBITORS
ES2178036T3 (en) CYCLOSPORINE DERIVATIVES, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN YOU.
ES2188604T3 (en) HIV PROTEASE INHIBITORS IN PHARMACEUTICAL COMBINATIONS FOR AIDS TREATMENT.
ES2157252T3 (en) APPLICATION OF RILUZOL IN THE TREATMENT OF NEURO-AIDS.
ES2174921T3 (en) HIV PROTEASE INHIBITORS.
MX9302681A (en) NEW QUINAZOLINS AS REVERSE HIV TRANSCRIPTASE INHIBITORS.
CO4130200A1 (en) HELPFUL HIV PROTEASE INHIBITORS IN AIDS TREATMENT
AR002957A1 (en) A COMBINATION OF USEFUL COMPOUNDS, THEIR USE TO PREPARE A MEDICINAL PRODUCT, AND A PHARMACEUTICAL COMPOSITION AND COMBINATION THAT CONTAIN THEM.
AR013758A1 (en) COMBINATION THERAPY FOR THE TREATMENT OF AIDS.
ECSP961660A (en) COMBINED THERAPY FOR HIV INFECTION
MX9700036A (en) Combination therapy for hiv infection.
ES2190456T3 (en) COMBINATION OF HIV PROTEASE INHIBITORS.
ECSP982741A (en) COMBINED THERAPY FOR THE TREATMENT OF AIDS
ECSP003786A (en) RANGE-HYDROXIL-2 (FLUOROALQUILOAMINOCARBONIL) -1-PIPERACINAPENTANAMIDAS AND USES OF THEM
DOP2001000263A (en) AZA AND POLIAZA-NAFTALENIL CARBOXAMIDES USEFUL AS INHIBITORS OF HIV INTEGRESS
KR970703770A (en) Combination therapy for HIV infection